As the PI3K signaling pathway and HDAC both are commonly dysregulated in SCLC cells, we wondered whether dual inhibition of phosphoinositide 3-kinase class I and pan histone deacetylase enzymes is effective in treating SCLC cells. Here, PIK3CA is linked to small cell lung carcinoma.